lilly glp-1 drug A Pill May Help You Keep Weight Off After Stopping Wegovy or Zepbound Eli Lilly stock soars on

Medicare has never paid for weight-loss drugs at scale

Conclusion A population pharmacokinetic model incorporating allometric scaling was developed to simultaneously describe the PK of semaglutide in all animal species and predict its PK in humans

We report an unusual case of diabetic ketoalkalosis, a mixed acid-base disorder, in a 57-year-old female patient with insulin-dependent T2DM following a switch to Mounjaro (tirzepatide)

There are no large trials proving safety, but early data suggests milk transfer is low

The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate

A New Era in Health?